# Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries

Study · id `cardio:ct-nct07353905` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07353905](<https://clinicaltrials.gov/study/NCT07353905>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07353905

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

## Technical summary

Registry record NCT07353905. Randomized; single masking; primary purpose treatment. Start 2025-12-12 (actual); primary completion 2028-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT07353905, source copy `cardio:ctgov-nct07353905-2026-07-09`, retrieved 2026-10-31)
- Started: 2025-12-12 (actual) (ClinicalTrials.gov record NCT07353905, source copy `cardio:ctgov-nct07353905-2026-07-09`, retrieved 2026-10-31)
- Primary completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT07353905, source copy `cardio:ctgov-nct07353905-2026-07-09`, retrieved 2026-10-31)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07353905, source copy `cardio:ctgov-nct07353905-2026-07-09`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT07353905, source copy `cardio:ctgov-nct07353905-2026-07-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07353905-2026-07-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
- Acronym: INVIGOR
- Condition: Peripheral Arterial Disease
- Condition: Lower Extremity Arterial Disease
- Intervention (Device): Intravascular Ultrasound (IVUS)
- Intervention (Device): Angiographic-guided Intervention
- Lead sponsor: Baylor Research Institute
- Lead sponsor class: OTHER
- Collaborator: Philips Healthcare
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: Philips Healthcare (`cardio:org-philips-healthcare`)

## Provenance

Content hash: bcb4130cafddbcc53a6aff23f89cb163d1122b02a81997231159a431070f43f6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
